Cellectis
(NASDAQ) CLLS
Cellectis Financials at a Glance
Market Cap
$232.89MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$68.09M
Net Income (TTM)
-$67.29M
EPS (TTM)
-$0.67
P/E Ratio
-4.78
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$3.18
Volume
448
Open
$3.28
Price
$3.18
Volume
448
Open
$3.28
Previous Close
$3.18
Daily Range
$3.18 - $3.30
52-Week Range
$1.57 - $5.48
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.36 (Average)
Price
$3.18
Volume
448
Open
$3.28
Previous Close
$3.18
Daily Range
$3.18 - $3.30
52-Week Range
$1.57 - $5.48
Estimated Earnings Date
Aug 11, 2026
CLLS News
Is Cellectis SA Stock a Buy Now?
CLLS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cellectis
Industry
Biotechnology
Sector
Health CareEmployees
229
CEO
André Choulika, PhD
Website
www.cellectis.comHeadquarters
Paris, IF 75013, FR
CLLS Financials
Key Financial Metrics (TTM)
Gross Margin
78.86%
Operating Margin
-69.23%
Net Income Margin
-98.69%
Return on Equity
-80.61%
Return on Capital
-16.89%
Return on Assets
-23.26%
Earnings Yield
-20.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$232.89MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
72.33M
Volume
448
Avg. Volume
38.55K
Financials (TTM)
Gross Profit
$55.76M
Operating Income
-$46.00M
EBITDA
-$51.11M
Operating Cash Flow
-$37.91M
Capital Expenditure
-$2.23M
Free Cash Flow
-$40.14M
Cash & ST Invst.
$185.66M
Total Debt
$108.60M
Cellectis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.80M
-45.6%
Gross Profit
$1.25M
-85.6%
Gross Margin
21.50%
N/A
Market Cap
$232.89MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.08M
N/A
Employees
216
N/A
Net Income
-$17.83M
+1.6%
EBITDA
-$22.55M
-99.8%
Quarterly Fundamentals
Total Cash
$185.66M
-23.2%
Total Debt
$108.60M
+18.3%
Accounts Receivable
$15.05M
-41.0%
Inventory
$0.00
N/A
Long Term Debt
$93.45M
+18.5%
Short Term Debt
$15.16M
+17.5%
Return on Assets
-23.26%
N/A
Return on Invested Capital
-30.50%
N/A
Free Cash Flow
-$15.82M
+9.9%
Operating Cash Flow
-$15.56M
+9.3%